fda approval semaglutide mash 🎉Exciting news that is now approved for (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Semaglutide Gets FDA Greenlight for

All three trials were sponsored by the manufacturer (Bayer), raising the possibility of reporting bias

As you journal how youre feeling, remember to consistently report back to your providers so they can give advice and even potentially adjust your treatment plan or GLP-1 medication to best suit your unique needs

Our programs feature flat-rate pricing with zero hidden fees, zero consultation charges, and no dose-change surcharges

Always consult a healthcare provider before combining treatments to ensure safety and effectiveness.

WHAT TO EXPECT: MONTH-BY-MONTH TIMELINE GLP-1 therapy is a gradual process

Topiramate may also cause a rash with blisters and peeling skin over much of the body that may cause death (toxic epidermal necrolysis)